Overview

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find molecular signs (biomarkers) to better understand the role of green tea as an anti-cancer and anti-inflammation agent in women with newly-diagnosed ductal carcinoma in situ (DCIS).
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago